Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Pharma Data Strategy Boosting Marketing and Prescription ROI
Pharma data strategy empowers marketers to unify HCP engagement, integrate analytics, automate compliance, and drive consistent prescription growth and ROI.
|
How the Best Healthcare Digital Marketing Agency Scales
Pharma marketing in India has no shortage of pilots. Every quarter, a new “digital-first” idea is tested a chatbot here, a WhatsApp drip there, maybe a webinar series that looked exciting…
|
Pharma Sales Transformation Empowering Field Force RO
Pharma sales transformation empowers marketing leaders to align field and digital operations, automate compliance, and deliver measurable prescription growth ROI.
|
Adherence = Revenue: The Data Case Pharma CMOs Can’t Afford to Miss
Why Adherence is the Real Growth Lever: Let’s call it straight. For all the money pharma spends on marketing, the biggest gap isn’t awareness. It’s adherence. Doctors prescribe. Patients start. But…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
